30
Participants
Start Date
May 31, 2009
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
Ixabepilone
Escalation: Solution, intravenous (IV), 32-40 mg/m2, every 3 weeks, approximately 6 months
Cisplatin
Escalation: Solution, IV, 60-100 mg/m2, every 3 weeks, approximately 6 months
Ixabepilone
Expansion: Solution, IV, 32 mg/m2, every 3 weeks, approximately 6 months
Cisplatin
Expansion: Solution, IV, 60-80 mg/m2, every 3 weeks, approximately 6 months
Penn State Milton S. Hershey Medical Center, Hershey
Georgetown University Medical Center, Washington D.C.
Local Institution, Meldola (Fc)
Local Institution, Rimini
Local Institution, Lucca
The Cancer Institute Of New Jersey, New Brunswick
Local Institution, Viterbo
Lead Sponsor
R-Pharm
INDUSTRY